Biden proposes requiring Medicare and Medicaid to cover weight loss drugs


This recording was made using enhanced software.

Full story

As President Joe Biden wraps up his term, his administration is proposing that Medicare and Medicaid cover popular weight loss medications. The new rule would dramatically expand access to anti-obesity drugs like Wegovy, Ozempic and Mounjaro.

As of now, Medicare and Medicaid only cover these drugs if they’re prescribed to treat certain conditions like diabetes. This new proposal could provide coverage for patients looking to use them exclusively for weight loss.

QR code for SAN app download

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

The change would dramatically reduce out-of-pocket costs for the drugs, which can cost more than $1,000 for a month’s supply, according to the White House. The CDC estimates more than 40% of Americans are considered obese and could benefit from these drugs.

The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people enrolled in Medicaid, White House officials said.

Shea Taylor (Producer) and Ian Kennedy (Lead Video Editor) contributed to this report.
Tags: , , , , , , , , , ,

Media landscape

Click on bars to see headlines

207 total sources

Key points from the Left

No summary available because of a lack of coverage.

Report an issue with this summary

Key points from the Center

No summary available because of a lack of coverage.

Report an issue with this summary

Key points from the Right

No summary available because of a lack of coverage.

Report an issue with this summary

Other (sources without bias rating):

Powered by Ground News™